Ni Made Dian Hartaningsih
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

KANKER PAYUDARA PADA WANITA USIA MUDA DI BAGIAN BEDAH ONKOLOGI RUMAH SAKIT UMUM PUSAT SANGLAH DENPASAR TAHUN 2002 – 2012 Ni Made Dian Hartaningsih; I Wayan Sudarsa
E-Jurnal Medika Udayana vol 3 no 6 (2014):e-jurnal medika udayana
Publisher : Universitas Udayana

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (179.836 KB)

Abstract

Penelitian ini bertujuan untuk mengetahui prevalensi kanker payudara pada wanita muda usia < 40 tahun, distribusi berdasarkan diagnosis histopatologi, stadium dan gradedari tahun 2002 – 2012.Penelitian ini merupakan penelitian deskriptif dengan desain potong lintang (crosssectional) dimana menggunakan data sekunder berupa catatan diagnosis dan rekammedis pasien kanker payudara dari Rumah Sakit Umum Pusat Sanglah Denpasar sejak2002 – 2012 yang dikumpulkan pada bulan November 2013. Variabel yang dinilai padapenelitian ini meliputi prevalensi, gambaran histopatologi, stadium dan grade padawanita muda penderita kanker payudara dengan usia < 40 tahun.Hasil penelitian menunjukkan selama periode 2002-2012 tercatat 22,7% (199 kasus)kanker payudara pada usia muda dengan jumlah kasus terbanyak terdapat padakelompok usia 35 – 39 tahun sebesar 57,8% (115 kasus). Diagnosis histopatologiterbanyak sebesar 81,9% (163 kasus) adalah tipe karsinoma duktal invasif. Stadium IIIB (36,7% atau 73 kasus) dan Grade II (46,2% atau 92 kasus) menempati angkaterbanyak selama periode tersebut. Dapat disimpulkan bahwa jumlah kasus kanker payudara pada usia muda dalam studiini cukup tinggi jika dibandingkan dengan kelompok usia lain yakni sebesar 22,7 %,mayoritas kasus terjadi pada kelompok usia 36-40 tahun, karsinoma duktal invasifmerupakan diagnosis histopatologi terbanyak, dan Stadium III B maupun grade IImenempati jumlah terbanyak pada periode tersebut.  
Does omega-3 supplementation added to exercise attenuate inflammaging? Effects on circulating interleukin-6 in older adults: A meta-analysis of randomized controlled trials Hartaningsih, Ni Made Dian; Wihandani, Desak Made; Ruma, I Made Winarsa; Prabawa, I Putu Yuda
Physical Therapy Journal of Indonesia Vol. 7 No. 1 (2026): Inpress January-June 2026
Publisher : Universitas Udayana dan Diaspora Taipei Medical University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/ptji.v7i1.398

Abstract

Background: Low-grade systemic inflammation (inflammaging) characterizes older adults, with circulating interleukin-6 (IL-6) as a key biomarker linked to frailty, physical decline, and cardiometabolic risk. Exercise repeatedly elicits anti-inflammatory myokine responses, while long-chain omega-3 (eicosapentaenoic Acid (EPA)/ docosahexaenoic acid (DHA)) promotes resolution of inflammation via membrane remodelling and specialized pro-resolving mediators. This study aimed to determine whether adding omega-3 supplementation to structured exercise reduces resting IL-6 more than exercise alone in older adults. Methods: A systematic search was undertaken in PubMed using a pre-specified medical subject headings (MeSH) strategy that combined terms for long-chain omega-3 fatty acids, structured exercise/physical activity, Interleukin-6, the aged population, and randomized/clinical trial filters; animal-only studies were excluded. This search yielded 22 records. Complementary searches in Scopus (14 records) and ResearchGate (18 records) were pooled with PubMed results and deduplicated prior to screening. Four RCTs (duration 8–18 weeks) met all criteria. Pooled effects were estimated with a random-effects model using restricted maximum likelihood (REML). Between-study heterogeneity was summarized by Q, I², and τ² summarized between-study heterogeneity. Potential small-study effects were explored visually using a funnel plot. Results: Pooled analysis using a REML model shows that post-intervention IL-6 was lower by 0.77 pg/mL when omega-3 supplementation was added to exercise versus exercise alone (MD = −0.77 pg/mL; 95% CI −1.46 to −0.08; p = 0.03; k = 4), indicating a statistically significant, directionally consistent attenuation of resting inflammation. Between-study heterogeneity was moderate (Q = 7.04, df = 3, p = 0.07; I² = 55%; τ² = 0.26), suggesting that differences in trial characteristics (e.g., duration 8–18 weeks, exercise mode, and omega-3 dose/form) contributed to variability in effect sizes. Funnel-plot analysis did not reveal marked asymmetry. Conclusion: Across randomized trials in older adults, omega-3 supplementation added to exercise achieves a modest but statistically significant reduction in resting IL-6 versus exercise alone, consistent with attenuation of inflammaging.